Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06592378 · ClinicalTrials.gov registry record · NA
Opioid Management for Discharged Emergency Department Patients
A NA study of Bone Fractures, sponsored by Addinex Technologies.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06592378 is a NA study of Bone Fractures that is actively recruiting participants, run by Addinex Technologies. The registered enrollment target is 100 participants. The trial reports 1 study location across 1 state.
The verdict
NCT06592378, a NA study of Bone Fractures, is actively recruiting participants, sponsored by Addinex Technologies.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this study is to analyze the use of the Addinex system for opioid dispensing after ambulatory care to determine whether it will reduce opioid consumption, increase pill disposal, show variables that may predict opioid consumption, and determine whether this intervention is acceptable to patients.
Conditions Studied
Interventions
- DEVICE Addinex
- DEVICE Standard Pill Bottle
Study Locations (1)
Rhode Island
- Rhode Island Hospital/Lifespan - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2025-06-27 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06592378
The ClinicalTrials.gov registry entry for NCT06592378 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Addinex Technologies, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bone Fractures appearing as the primary indexed condition, and to 2 interventions - of which Addinex is the first listed.
NCT06592378 reports 1 study location spanning 1 distinct geographic area - top geographies include Rhode Island.
Frequently Asked Questions
What is clinical trial NCT06592378 about?
NCT06592378 is a clinical study titled "Opioid Management for Discharged Emergency Department Patients". The goal of this study is to analyze the use of the Addinex system for opioid dispensing after ambulatory care to determine whether it will reduce opioid consumption, increase pill disposal, show variables that may predict opioid consumption, and determine whether this intervention is acceptable to ...
What is the current status of trial NCT06592378?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2025-06-27. Estimated completion is 2026-06-30.
What conditions does trial NCT06592378 study?
This clinical trial studies the following conditions: Bone Fractures.
What interventions are being tested in trial NCT06592378?
The interventions under investigation include: Addinex (DEVICE), Standard Pill Bottle (DEVICE).
Who is sponsoring clinical trial NCT06592378?
This trial is sponsored by Addinex Technologies, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06592378 being conducted?
This trial has 1 study location across Rhode Island. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.